Crossmark

Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of type II Diabetes and its Risk factors (EMPOWER-D) - A Protocol for a Cluster Randomised Controlled Trial

Crossref DOI link: https://doi.org/10.1186/s12889-025-24371-y

Published Online: 2025-10-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rehman, Khalid

Tahir, Amber

Imtiaz, Sara

Khan, Zohaib

Afaq, Saima

Khan, Asima

Shah, Inayat

Kanaan, Mona

Sanauddin, Noor

Khaleeq, Nadia

Abdeali, Mariam

Walker, Simon

Ahmed, Farrukh

Jennings, Hannah Maria

Ali, Sajid

Fazid, Sheraz

Shahab, Abdul Rahman

Khattak, Maria Ishaq

Zafar, Rubia

Basit, Abdul

Siddiqi, Kamran

Haq, Zia Ul
Funding

Funding for this research was provided by:

National Institute for Health and Care Research (NIHR203248)
License Information

Text and Data Mining valid from 2025-10-14

Version of Record valid from 2025-10-14
More Information

Article History

Received: 19 December 2024

Accepted: 8 August 2025

First Online: 14 October 2025

Declarations

:

: The EMPOWER-D protocol has been approved by the National Bioethics Committee of Pakistan (NBC-R-1070). We also got ethics approvals from Ethics Review Committee of The Aga Khan University (2024-9340-28927), Khyber Medical University (KMU/IPHSS/Ethics/2023/EO/0136), and. The trial has been registered at Clinicaltrial.gov (NCT06561126).Written informed consent will be taken from all participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below